Palliative Care for Critical Illness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a hospice and palliative care specialist in a medical intensive care unit (ICU) can improve patient outcomes and reduce healthcare usage. The specialist provides timely and proactive consultations to ICU patients. The study compares the results of patients who receive this care to those who do not and to past patients. Suitable candidates for this trial are individuals currently admitted to a medical ICU at a major referral center. As an unphased trial, this study offers patients the chance to contribute to innovative care practices that could enhance ICU experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that embedding a hospice and palliative care practitioner in an ICU is safe?
Research has shown that hospice and palliative care specialists in intensive care units are safe for patients. One study examined data from nearly 20,000 patients who received hospice or palliative care over three years and found no major safety issues. Instead, patient outcomes improved. This indicates that involving a palliative care expert in patient care does not increase risk.
These findings reassure that involving hospice and palliative care professionals is generally well-accepted. While this trial has a unique approach, existing evidence suggests it is safe.12345Why are researchers excited about this trial?
Researchers are excited about the embedded hospice and palliative care practitioner approach because it directly integrates specialized care into the medical intensive care unit (ICU) setting. Unlike standard care, which typically involves separate hospice and palliative consultations, this method involves having a dedicated practitioner present in the ICU. This integration aims to provide continuous, personalized support and symptom management for critically ill patients right where they are treated. By potentially improving communication and decision-making, this approach could lead to better patient outcomes and enhanced quality of life during critical illness.
What evidence suggests that embedding a hospice and palliative care practitioner in the ICU could improve patient outcomes?
Research has shown that hospice and palliative care specialists in Intensive Care Units (ICUs) can improve patient outcomes. In this trial, one arm involves a prospective hospice and palliative care intervention where patients receive care from an embedded hospice and palliative care practitioner. A study of nearly 20,000 patients found improvements such as better care planning and more family meetings. Another report found that palliative care teams in ICUs increased the number of consultations and follow-up visits. This approach helps patients and families make informed decisions about care, enhancing their experience during serious illness. Overall, palliative care in ICUs is linked to positive changes that benefit patients with severe health issues.16789
Who Is on the Research Team?
Stephen Chi, MD
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
This trial is for patients in a medical intensive care unit (MICU) who may benefit from additional support focused on quality of life and end-of-life issues. There are no specific inclusion or exclusion criteria provided, suggesting it's broadly applicable within the MICU setting.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Embedding a hospice and palliative care practitioner within the medical ICU to offer proactive consultations
Follow-up
Participants are monitored for outcomes such as ICU length of stay, code status changes, and healthcare utilization
What Are the Treatments Tested in This Trial?
Interventions
- Embedded Hospice and Palliative Care Practitioner
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor